ABLYNX: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
What changed
ABLYNX
NACE 72.101, Research and development on biotechnology
financial year 2024 against 2025filed annual accounts (NBB)
Net result for the year
€3.7m
2024 · -€32.1m+€35.7m
Equity
€359.2m
2024 · €355.5m+€3.7m
Cash
-
2024 · €16,605-€16,605
Balance sheet total
€417.3m
2024 · €442.2m-€24.9m
Largest movements
Assets
- Receivables within one year -€33.0m
down €33.0m (-8.3%), from €398.8m to €365.8m
of which Other amounts receivable: -€35.8m
Equity and liabilities
- Trade debts -€24.5m
down €24.5m (-36.4%), from €67.2m to €42.7m
- Provisions -€5.2m
down €5.2m (-79.7%), from €6.6m to €1.3m
Income statement
- Turnover +€25.0m
up €25.0m (+20.3%), from €122.9m to €147.9m
- Services and other goods -€12.8m
down €12.8m (-10.6%), from €120.3m to €107.6m
- Provisions -€11.4m
down €11.4m, from €6.2m to -€5.2m
- Depreciation -€10.0m
down €10.0m (-6.7%), from €148.6m to €138.7m
- Financial income -€5.3m
down €5.3m (-34.6%), from €15.3m to €10.0m
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Result 2024
-€32.1m
Turnover
+€25.0m
Other operating income
-€4.5m
Goods and materials
-€59,944
Services and other goods
+€12.8m
Staff costs
-€3.8m
Depreciation
+€10.0m
Provisions
+€11.4m
Other operating charges
+€51,544
Other operating items
-€10.4m
Financial income
-€5.3m
Financial charges
+€602,381
Taxes
-€334
Result 2025
€3.7m
Cash bridge derived
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
From operations
+€142.9m
Investment
-€142.9m
Financing
+€12,364
Cash 2024
€16,605
From operations (derived)
+€142.9m
Net result for the year
+€3.7m
Depreciation
+€138.7m
Receivables after one year
-€4.1m
Receivables within one year
+€33.0m
Smaller working-capital items
+€119,597
Provisions
-€5.2m
Trade debts
-€24.5m
Tax, wage and social debts
+€1.3m
Investment (derived)
-€142.9m
Investment in fixed assets (net)
-€142.9m
Financing
+€12,364
Short-term financial debts
+€12,364
Cash 2025
€0
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €442,183,145 | €417,332,640 | -€24.9m | -5.6% |
| Fixed assets | 21/28 | €20,904,561 | €25,150,757 | +€4.2m | +20.3% |
| Intangible fixed assets | 21 | €70,698 | €83,732 | +€13,034 | +18.4% |
| Tangible fixed assets | 22/27 | €20,833,863 | €25,067,025 | +€4.2m | +20.3% |
| Land and buildings | 22 | €1,088,987 | €2,977,050 | +€1.9m | +173.4% |
| Plant, machinery and equipment | 23 | €17,111,133 | €18,160,065 | +€1.0m | +6.1% |
| Furniture and vehicles | 24 | €215,448 | €415,520 | +€200,072 | +92.9% |
| Other tangible fixed assets | 26 | €2,418,294 | €3,514,391 | +€1.1m | +45.3% |
| Current assets | 29/58 | €421,278,584 | €392,181,883 | -€29.1m | -6.9% |
| Amounts receivable after more than one year | 29 | €20,197,599 | €24,310,761 | +€4.1m | +20.4% |
| Other amounts receivable | 291 | €20,197,599 | €24,310,761 | +€4.1m | +20.4% |
| Amounts receivable within one year | 40/41 | €398,805,871 | €365,830,189 | -€33.0m | -8.3% |
| Trade receivables | 40 | €44,887,918 | €47,754,574 | +€2.9m | +6.4% |
| Other amounts receivable | 41 | €353,917,953 | €318,075,615 | -€35.8m | -10.1% |
| Cash at bank and in hand | 54/58 | €16,605 | - | -€16,605 | |
| Deferred charges and accrued income | 490/1 | €2,258,508 | €2,040,933 | -€217,575 | -9.6% |
| Total equity and liabilities | 10/49 | €442,183,145 | €417,332,640 | -€24.9m | -5.6% |
| Equity | 10/15 | €355,521,152 | €359,208,267 | +€3.7m | +1.0% |
| Contributions | 10/11 | €306,531,176 | €306,531,176 | = | 0.0% |
| Capital | 10 | €161,891,574 | €161,891,574 | = | 0.0% |
| Issued capital | 100 | €161,891,574 | €161,891,574 | = | 0.0% |
| Contributions outside capital | 11 | €144,639,603 | €144,639,603 | = | 0.0% |
| Share premium | 1100/10 | €144,639,603 | €144,639,603 | = | 0.0% |
| Reserves | 13 | €9,715,326 | €9,899,682 | +€184,356 | +1.9% |
| Non-distributable reserves | 130/1 | €9,715,326 | €9,899,682 | +€184,356 | +1.9% |
| Legal reserve | 130 | €9,715,326 | €9,899,682 | +€184,356 | +1.9% |
| Profit (loss) carried forward | 14 | €39,274,649 | €42,777,409 | +€3.5m | +8.9% |
| Provisions and deferred taxes | 16 | €6,577,193 | €1,333,515 | -€5.2m | -79.7% |
| Provisions for liabilities and charges | 160/5 | €6,577,193 | €1,333,515 | -€5.2m | -79.7% |
| Other liabilities and charges | 164/5 | €6,577,193 | €1,333,515 | -€5.2m | -79.7% |
| Amounts payable | 17/49 | €80,084,800 | €56,790,858 | -€23.3m | -29.1% |
| Amounts payable within one year | 42/48 | €75,685,455 | €52,489,491 | -€23.2m | -30.6% |
| Financial debts | 43 | - | €12,364 | +€12,364 | |
| Other loans | 439 | - | €12,364 | +€12,364 | |
| Trade debts | 44 | €67,161,379 | €42,685,727 | -€24.5m | -36.4% |
| Suppliers | 440/4 | €67,161,379 | €42,685,727 | -€24.5m | -36.4% |
| Taxes, remuneration and social security | 45 | €8,524,076 | €9,791,400 | +€1.3m | +14.9% |
| Taxes | 450/3 | - | €35,000 | +€35,000 | |
| Remuneration and social security | 454/9 | €8,524,076 | €9,756,400 | +€1.2m | +14.5% |
| Accrued charges and deferred income | 492/3 | €4,399,346 | €4,301,367 | -€97,978 | -2.2% |
| Operating income | 70/76A | €287,636,126 | €297,755,114 | +€10.1m | +3.5% |
| Turnover | 70 | €122,909,591 | €147,918,811 | +€25.0m | +20.3% |
| Own construction capitalised | 72 | €143,281,224 | €132,876,991 | -€10.4m | -7.3% |
| Other operating income | 74 | €21,445,311 | €16,959,312 | -€4.5m | -20.9% |
| Operating charges | 60/66A | €331,621,910 | €301,310,774 | -€30.3m | -9.1% |
| Goods for resale, raw materials and consumables | 60 | €3,235,562 | €3,295,506 | +€59,944 | +1.9% |
| Purchases | 600/8 | €3,235,562 | €3,295,506 | +€59,944 | +1.9% |
| Services and other goods | 61 | €120,324,096 | €107,559,123 | -€12.8m | -10.6% |
| Remuneration, social security and pensions | 62 | €53,148,881 | €56,972,276 | +€3.8m | +7.2% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €148,631,375 | €138,672,081 | -€10.0m | -6.7% |
| Provisions for liabilities and charges: additions (uses and reversals) | 635/8 | €6,192,403 | -€5,243,678 | -€11.4m | |
| Other operating charges | 640/8 | €80,531 | €28,987 | -€51,544 | -64.0% |
| Non-recurring operating charges | 66A | €9,062 | €26,479 | +€17,417 | +192.2% |
| Operating profit (loss) | 9901 | -€43,985,785 | -€3,555,660 | +€40.4m | +91.9% |
| Financial income | 75/76B | €15,316,531 | €10,023,965 | -€5.3m | -34.6% |
| Recurring financial income | 75 | €15,316,531 | €10,023,965 | -€5.3m | -34.6% |
| Income from current assets | 751 | €12,482,576 | €7,032,132 | -€5.5m | -43.7% |
| Other financial income | 752/9 | €2,833,955 | €2,991,832 | +€157,877 | +5.6% |
| Financial charges | 65/66B | €3,348,570 | €2,746,189 | -€602,381 | -18.0% |
| Recurring financial charges | 65 | €3,348,570 | €2,746,189 | -€602,381 | -18.0% |
| Debt charges | 650 | €361,255 | €284,502 | -€76,752 | -21.2% |
| Other financial charges | 652/9 | €2,987,316 | €2,461,686 | -€525,629 | -17.6% |
| Profit (loss) for the period before taxes | 9903 | -€32,017,824 | €3,722,116 | +€35.7m | |
| Income taxes | 67/77 | €34,666 | €35,000 | +€334 | +1.0% |
| Taxes | 670/3 | €34,666 | €35,000 | +€334 | +1.0% |
| Profit (loss) for the period | 9904 | -€32,052,490 | €3,687,116 | +€35.7m | |
| Profit (loss) for the period to be appropriated | 9905 | -€32,052,490 | €3,687,116 | +€35.7m |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 10 October 2026 via checked.be.